Detailed learning objectives and preliminary agenda are available here
Learning Objectives
CAGPO 2022 General Conference Learning Objectives
At the completion of this conference, the participant will:
- be able to evaluate data concerning major advances presented at ASCO 2022 and ESMO 2022;
- comprehend an approach to treatment for stage 3 and metastatic rectal cancer;
- comprehend recent advances in the treatment of Her2neu positive breast cancer, lung cancer and multiple myeloma;
- be able to apply knowledge acquired regarding the role of ethics in the delivery of oncology care;
- be able to implement the tools discussed in evaluating the role of systemic therapy for our geriatric patients;
- comprehend how COVID has affected the delivery of patient care for both medical and radiation oncology treatment plans;
- comprehend the role of MAID for oncology patients and how COVID has affected its delivery;
- acquire new knowledge in the treatment of electrolyte abnormalities and the availability of online tools from the perspective of the oncology pharmacist;
- acquire a working knowledge of the role of gene assays in treatment decision making for hormone receptor positive, Her2neu negative breast cancer;
- be able to apply knowledge acquired regarding the role of genetics’ assessments; and
- comprehend the recent changes to the treatment of cancer associated thrombosis.